Similar Items: Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer
- First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307
- Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
- Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
- Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification
- HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
- HER2 Expression and Axillary Metastasis in Treatment-Naïve Early Breast Cancer